X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Lupin Ltd with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD vs ACTAVIS (US) - Comparison Results

LUPIN LTD    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 LUPIN LTD   ACTAVIS
EQUITY SHARE DATA
    LUPIN LTD
Mar-18
ACTAVIS
Dec-14
LUPIN LTD/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,46519,644-   
Low Rs72711,982-   
Sales per share (Unadj.) Rs349.63,537.4-  
Earnings per share (Unadj.) Rs5.6-441.4-  
Cash flow per share (Unadj.) Rs29.6324.5-  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs300.37,672.5-  
Shares outstanding (eoy) m452.08265.90-   
Bonus/Rights/Conversions ESOPS--  
Price / Sales ratio x3.14.5 70.1%   
Avg P/E ratio x197.2-35.8 -550.5%  
P/CF ratio (eoy) x37.148.7 76.1%  
Price / Book Value ratio x3.62.1 177.1%  
Dividend payout %90.00-   
Avg Mkt Cap Rs m495,5024,204,782 11.8%   
No. of employees `00017.021.6 78.9%   
Total wages/salary Rs m28,6470-   
Avg. sales/employee Rs Th9,273.643,546.0 21.3%   
Avg. wages/employee Rs Th1,681.00-   
Avg. net profit/employee Rs Th147.4-5,434.1 -2.7%   
INCOME DATA
Net Sales Rs m158,042940,595 16.8%  
Other income Rs m1,504-2,348 -64.0%   
Total revenues Rs m159,545938,247 17.0%   
Gross profit Rs m31,475120,833 26.0%  
Depreciation Rs m10,859203,673 5.3%   
Interest Rs m2,04429,668 6.9%   
Profit before tax Rs m20,076-114,856 -17.5%   
Minority Interest Rs m-710-   
Prior Period Items Rs m350-   
Extraordinary Inc (Exp) Rs m-14,644-8,425 173.8%   
Tax Rs m2,885-5,905 -48.9%   
Profit after tax Rs m2,513-117,376 -2.1%  
Gross profit margin %19.912.8 155.0%  
Effective tax rate %14.45.1 279.5%   
Net profit margin %1.6-12.5 -12.7%  
BALANCE SHEET DATA
Current assets Rs m122,095495,573 24.6%   
Current liabilities Rs m50,956361,418 14.1%   
Net working cap to sales %45.014.3 315.6%  
Current ratio x2.41.4 174.7%  
Inventory Days Days8558 145.8%  
Debtors Days Days12066 180.9%  
Net fixed assets Rs m129,876114,856 113.1%   
Share capital Rs m9040-   
"Free" reserves Rs m134,8660-   
Net worth Rs m135,7712,040,115 6.7%   
Long term debt Rs m64,2451,069,060 6.0%   
Total assets Rs m263,0543,738,860 7.0%  
Interest coverage x10.8-2.9 -377.0%   
Debt to equity ratio x0.50.5 90.3%  
Sales to assets ratio x0.60.3 238.8%   
Return on assets %1.7-2.3 -73.8%  
Return on equity %1.9-5.8 -32.2%  
Return on capital %3.7-3.0 -123.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m33,8070-   
CASH FLOW
From Operations Rs m17,512161,518 10.8%  
From Investments Rs m-14,073-386,737 3.6%  
From Financial Activity Rs m-14,921217,290 -6.9%  
Net Cashflow Rs m-11,482-7,928 144.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 72.01 Rs / USD

Compare LUPIN LTD With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare LUPIN LTD With: SHASUN PHARMA  NATCO PHARMA  GLENMARK PHARMA  PFIZER  TTK HEALTHCARE  



Today's Market

Sensex Trades 370 Points Up; Hero MotoCorp & Tata Motors Gain Over 5%(12:30 pm)

Stock markets in India are presently trading higher following the outcome of assembly polls announced on Tuesday.

Related Views On News

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

LUPIN LTD Announces Quarterly Results (1QFY19); Net Profit Up 21.3% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, LUPIN LTD has posted a net profit of Rs 4 bn (up 21.3% YoY). Sales on the other hand came in at Rs 26 bn (up 3.2% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


Dec 12, 2018 03:35 PM

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LUPIN LTD 8-QTR ANALYSIS

COMPARE LUPIN LTD WITH

MARKET STATS